Delivery Order SPE2DB22D2005-SPE2DB25FJSP5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,962.20 to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), a broad-spectrum antiviral medication. This firm fixed-price delivery order, issued on June 3, 2025, with an ultimate completion date of June 25, 2025, represents a non-competitive award under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,981.10 to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), an antiviral medication. This firm fixed-price delivery order, issued on September 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury (remdesivir) 100 mg vials valued at $15,848.80 under a firm fixed-price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 mg vials of Veklury (remdesivir) with a potential value of $6,809.20. The award has a completion date of February 28, 2024. Amerisourcebergen Drug Corp, based in Conshohocken, Pennsylvania, is a for-profit prime contractor that provides a wide range of pharmaceutical products and medical supplies to government...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $13,618.40 contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a COVID-19 treatment medication. The contract has a completion date of February 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,042.76 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a key therapeutic used to treat COVID-19. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
- This federal contract award, valued at $18,725.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. It is a firm-fixed-price delivery order contract with a completion date of December 4, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The contract is valued at $17,023.00 and has a completion date of August 16, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen, through its extensive supply chain and distribution capabilities, will provide this critical antiviral medication to support various...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,803.40 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp. for the supply of 100 mg Veklury (Remdesivir) vials. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a broad range of pharmaceutical products and medical supplies for military healthcare programs. The contract has no set-aside designation, indicating open...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $20,427.60 firm fixed price contract has an ultimate completion date of October 29, 2024. This award is a task order under AmerisourceBergen's Indefinite Delivery Contract valued up to $999,999,999 with DLA Troop Support Medical for a wide range of pharmaceutical and medical...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSP5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,943.30 to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), an antiviral medication used in treating severe COVID-19 infections. This firm fixed-price delivery order, awarded on August 26, 2025, represents a non-competitive child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of September 17, 2025. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and the Defense Health Agency. The company's role as a pharmaceutical prime vendor through the DLA Troop Support Medical contract enables it to fulfill diverse federal medical supply requirements across multiple therapeutic domains. This particular delivery order exemplifies the routine pharmaceutical procurement activities conducted under the broader prime vendor contract vehicle, which supports ongoing military healthcare operations domestically and globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 8/26/25 |